Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
Public ClinicalTrials.gov record NCT00228540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An 8-week, Open-Label Study to Characterize the Response to Modafinil (85mg Film-Coated Tablet) Treatment at Dosages up to 425mg/Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period)
Study identification
- NCT ID
- NCT00228540
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2005
- Primary completion
- Not listed
- Completion
- Aug 31, 2006
- Last update posted
- May 8, 2014
2005 – 2006
United States locations
- U.S. sites
- 39
- U.S. states
- 22
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melmed Center | Scottsdale | Arizona | 85254 | — |
| UCI Child Development Center | Irvine | California | 92612 | — |
| Pharmacology Research Institut | Northridge | California | 91324 | — |
| Pacific Sleep Medicine Service | San Diego | California | 92121 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Clinical Neuroscience Solution | Jacksonville | Florida | 32216 | — |
| Clinical Neurosciences | Orlando | Florida | 32806 | — |
| Laszlo J. Mate, MD, PA | West Palm Beach | Florida | 33407 | — |
| Northwest Behavioral Research | Marietta | Georgia | 30060 | — |
| Pediatrics and Adolescent | Woodstock | Georgia | 30189 | — |
| Loyola University Medical Center Department of Psychiatry | Maywood | Illinois | 60153 | — |
| HALP Clinic and ADHD Research | Northbrook | Illinois | 60062 | — |
| Cientifica, Inc. | Wichita | Kansas | 67207 | — |
| Michael J. Rieser, MD | Lexington | Kentucky | 40509 | — |
| Pedia Research, LLC | Owensboro | Kentucky | 42301 | — |
| Louisiana Research Associates | New Orleans | Louisiana | 70114 | — |
| Psycopharmacology Research - LSU Health Science Center | Shreveport | Louisiana | 71103 | — |
| Massachusetts General Hospital | Cambridge | Massachusetts | 02138 | — |
| Odyssey Research | Dearborn | Michigan | 48126 | — |
| Hurley Medical Center | Flint | Michigan | 48503 | — |
| ProMed HealthCare | Kalamazoo | Michigan | 49008 | — |
| Regions Hospital | Saint Paul | Minnesota | 55101 | — |
| Odyssey Research | McCook | Nebraska | 69001 | — |
| University of Nebraska | Omaha | Nebraska | 68198-7630 | — |
| Bancroft Clinical Research | Cherry Hill | New Jersey | 08034 | — |
| Hunterdon Pediatric Associates | Flemington | New Jersey | 08822 | — |
| Odyssey Research | Bismarck | North Dakota | 58501 | — |
| Prairie at Saint John's | Fargo | North Dakota | 58104 | — |
| Odyssey Research | Minot | North Dakota | 58701 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229 | — |
| OCCI, Inc Salem | Salem | Oregon | 97301 | — |
| Medical University of SC | Charleston | South Carolina | 29425 | — |
| UT Medical Group | Memphis | Tennessee | 38105 | — |
| Clinical Neuroscience Solution | Memphis | Tennessee | 38119 | — |
| Claghorn-Lesem Research | Bellaire | Texas | 77401 | — |
| The Clinical Study Ceneter | Burlington | Vermont | 05401 | — |
| Dominion Clinical Research | Midlothian | Virginia | 23112 | — |
| Advanced Pediatrics | Vienna | Virginia | 22180 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated ADHD trials
Other public records listing ADHD. Sorted by last update posted; newest first. Not a recommendation.
- NCT07784348: Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD Recruiting
- NCT07717892: A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD Recruiting
- NCT07717879: A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD Recruiting
- NCT07661823: QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428 Not yet recruiting
- NCT07684417: Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study Not yet recruiting
- NCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00228540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2014 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00228540 live on ClinicalTrials.gov.